EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Clinical trials for EXTENSIVE-STAGE SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE-STAGE SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for EXTENSIVE-STAGE SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer drug combo trial halted early – what we know
Disease control TerminatedThis study tested whether a new combination of drugs (bemarituzumab plus anlotinib) works better than the standard treatment (tislelizumab) for people with extensive-stage small cell lung cancer. The trial was stopped early and included 40 adults aged 18-75. The goal was to see i…
Matched conditions: EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Lung cancer combo trial halted early – only 10 patients enrolled
Disease control TerminatedThis study tested a new drug (hSTC810) combined with chemotherapy (paclitaxel) in people with advanced small cell lung cancer that returned after initial treatment. The goal was to see if the combination is safe and shrinks tumors. Only 10 patients took part before the study was …
Matched conditions: EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: STCube, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Lung cancer combo trial halted early – did it help?
Disease control TerminatedThis study tested whether adding vorolanib to the standard maintenance drug atezolizumab could extend the time people with extensive-stage small cell lung cancer stay cancer-free after initial chemotherapy. Only 11 participants were enrolled before the study was stopped early. Th…
Matched conditions: EXTENSIVE-STAGE SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC